Atlas Trials

Precision Biomarkers to Detect Brain Injury in Active-Duty United States Special Operations Forces With Repeated Blast Exposure

Clinical trial NCT07131475 · RECRUITING

Trial details

NCT number
NCT07131475
Sponsor
Massachusetts General Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Blast Injury
Start date
2025-10-14
Primary completion
2029-04-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.